Latest Headlines
-
STEMart Expands Comprehensive Portfolio Of High-Performance Chromatography Columns For Precision Laboratory Separations
3/26/2026
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its product line with the launch of Chromatography Columns.
-
Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay To Advance Proactive Monitoring In Next-Generation Immunotherapy
3/26/2026
Eurofins Viracor, a leader in advanced clinical diagnostics, today announced the launch of the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.
-
StarLIMS To Acquire The MODA Platform From Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control
3/25/2026
StarLIMS has agreed to acquire the MODA Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.
-
CorePlus And Ibex Expand Partnership With Clinical Deployment Of AI-Powered Diagnostics For TURP
3/25/2026
CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.
-
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, Alongside Key Partners 10x Genomics And Broad Clinical Labs
3/25/2026
Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative anchored by a partnership with 10x Genomics, Inc. (Nasdaq: TXG) and Broad Clinical Labs.
-
Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR To European Markets With CE Mark Clearance
3/25/2026
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology.
-
Productivity Enhancing Bioreactor For Scalable Organoid Culture
3/24/2026
Amsbio announce the RPMotion – a spinning organoid bioreactor that facilitates fast, easy and efficient organoid culture for drug discovery, disease modelling and regenerative medicine.
-
Bruker Showcases Analytical And Automation Innovations For Applied, Biopharma, Industrial And Academic Markets At Analytica 2026
3/24/2026
At Analytica 2026, Bruker highlights novel analytical systems and workflows for chemistry and life science research, applied, biopharma and industrial research and QC, including Chemspeed lab automation and SciY lab scientific and data management software.
-
Leica Biosystems Solidifies Leadership In Digital Pathology With Launch Of Next-Generation Aperio GT Elite Scanner And Aperio iQC Software
3/23/2026
Leica Biosystems, a Danaher Company and a global leader in anatomic pathology solutions, continues to enhance digital pathology workflows with the US launch of the Aperio GT EliteTM scanner, along with Aperio iQC software incorporating unique rescan functionality.
-
SPECTRO AI QUANT: Fast, Easy Semiquantitative ICP-OES Analysis For Modern Laboratories
3/23/2026
SPECTRO Analytical Instruments has introduced SPECTRO AI QUANT semiquantitative analysis software for SPECTRO ICP-OES instruments, enabling fast, easy semiquantitative elemental analysis of unknown samples.